KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Total Liabilities (2016 - 2025)

Boston Scientific's Total Liabilities history spans 17 years, with the latest figure at $19.4 billion for Q4 2025.

  • For Q4 2025, Total Liabilities rose 11.78% year-over-year to $19.4 billion; the TTM value through Dec 2025 reached $19.4 billion, up 11.78%, while the annual FY2025 figure was $19.4 billion, 11.78% up from the prior year.
  • Total Liabilities for Q4 2025 was $19.4 billion at Boston Scientific, down from $20.3 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $40.2 billion in Q1 2025 and bottomed at -$20.0 billion in Q1 2022.
  • The 5-year median for Total Liabilities is $16.5 billion (2023), against an average of $14.1 billion.
  • The largest annual shift saw Total Liabilities crashed 7790.94% in 2022 before it soared 118041.18% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $32.2 billion in 2021, then rose by 7.73% to $34.7 billion in 2022, then plummeted by 55.05% to $15.6 billion in 2023, then rose by 11.44% to $17.4 billion in 2024, then increased by 11.78% to $19.4 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Total Liabilities are $19.4 billion (Q4 2025), $20.3 billion (Q2 2025), and $40.2 billion (Q1 2025).